首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

全球牛短暫熱疫苗市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

市場調查報告書

商品編碼

1377846

全球牛短暫熱疫苗市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

Global Bovine Ephemeral Fever Vaccines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年09月01日 | 出版商:

Value Market Research | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球牛短暫發燒疫苗市場需求預計將從 2022 年的 72.35 萬美元達到 2030 年近 93.02 萬美元的市場規模，2023-2030 年研究期間CAGR為 3.19%。

牛短暫熱 (BEF)，通常也稱為三天病，是一種影響牛和水牛的病毒性疾病。 BEF 疫苗是為預防或控制這種疾病而開發的疫苗。

市場動態：

有牛短暫性熱爆發歷史的地區和疾病流行的地區依靠這些疫苗來保護牛隻和水牛群。這種疾病的經濟影響，包括牛奶產量減少和體重減輕，推動了需求，因為農民尋求保護他們的牲畜並保持生產力。政府措施通常涉及疫苗接種計劃，以控制和預防牛短暫熱病的爆發，從而進一步促進疫苗的使用。牲畜貿易的全球化擴大了市場，涵蓋了以前未受該疾病影響的地區。持續的研究和開發工作增強了疫苗配方和遞送方法，使其對生產者和使用者更具吸引力。提高意識、教育活動和監管批准進一步支持疫苗接種實踐。環境因素和昆蟲媒介控制也會影響牛短暫熱病的爆發，可能會增加對疫苗的需求。隨著研究、技術的進步和疾病動態的變化，牛短暫熱疫苗市場不斷發展，確保其在保護全球牛和水牛種群方面的相關性。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球牛短暫熱疫苗市場的各個細分市場進行了包容性評估。牛短暫熱疫苗產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲牛短暫發燒疫苗市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。牛短暫熱疫苗市場的主要參與者包括 Zoetis Inc、Onderstepoort Biological Products SOC Ltd、Green Cross Veterinary Products Co Ltd、獸醫血清和疫苗研究所以及 CAVAC（ChoongAng Vaccine Laboratories Co Ltd）。，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：牛短暫性發燒疫苗公司的競爭格局

牛短暫性發燒疫苗市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Zoetis Inc

公司簡介
公司收入
產品
最近的發展

Onderstepoort Biological Products SOC Ltd

公司簡介
公司收入
產品
最近的發展

Green Cross Veterinary Products Co Ltd

公司簡介
公司收入
產品
最近的發展

Veterinary Serum & Vaccine Research Institute

公司簡介
公司收入
產品
最近的發展

CAVAC ChoongAng Vaccine Laboratories Co Ltd

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112112314

The global demand for Bovine Ephemeral Fever Vaccines Market is presumed to reach the market size of nearly USD 93.02 MN by 2030 from USD 72.35 MN in 2022 with a CAGR of 3.19% under the study period 2023 - 2030.

Bovine ephemeral fever (BEF), also commonly referred to as three-day sickness, is a viral illness that impacts cattle and water buffalo. BEF vaccines are vaccines developed to prevent or control this disease.

MARKET DYNAMICS:

Regions with a history of bovine ephemeral fever outbreaks and areas where the disease is endemic rely on these vaccines to protect cattle and water buffalo herds. The economic impact of this disease, including reduced milk production and weight loss, drives demand as farmers seek to safeguard their livestock and maintain productivity. Government initiatives often involve vaccination programs to control and prevent bovine ephemeral fever outbreaks, further promoting vaccine use. The globalization of livestock trade has expanded the market, reaching regions previously unaffected by the disease. Ongoing research and development efforts enhance vaccine formulations and delivery methods, making them more attractive to producers and users. Increasing awareness, education campaigns, and regulatory approvals further support vaccination practices. Environmental factors and insect vector control also impact bovine ephemeral fever outbreaks, potentially increasing the need for vaccines. The bovine ephemeral fever vaccine market continues to evolve with advancements in research, technology, and changing disease dynamics, ensuring its relevance in protecting cattle and water buffalo populations globally.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bovine ephemeral fever vaccines. The growth and trends of bovine ephemeral fever vaccines industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the bovine ephemeral fever vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Live Vaccine
Killed Vaccine
Others

By Application

Cattle
Water Buffaloes

By End-User

Medical Device Companies
Pharmaceutical Industries
Animal Hospitals
Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Bovine Ephemeral Fever Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bovine Ephemeral Fever Vaccines market include Zoetis Inc, Onderstepoort Biological Products SOC Ltd, Green Cross Veterinary Products Co Ltd, Veterinary Serum & Vaccine Research Institute and CAVAC (ChoongAng Vaccine Laboratories Co Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BOVINE EPHEMERAL FEVER VACCINES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Live Vaccine Historic and Forecast Sales by Regions
5.5 Killed Vaccine Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Cattle Historic and Forecast Sales by Regions
6.5 Water Buffaloes Historic and Forecast Sales by Regions

7 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY END-USER

7.1 Overview by End-User
7.2 Historical and Forecast Data
7.3 Analysis by End-User
7.4 Medical Device Companies Historic and Forecast Sales by Regions
7.5 Pharmaceutical Industries Historic and Forecast Sales by Regions
7.6 Animal hospitals Historic and Forecast Sales by Regions
7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BOVINE EPHEMERAL FEVER VACCINES COMPANIES

9.1. Bovine Ephemeral Fever Vaccines Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BOVINE EPHEMERAL FEVER VACCINES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Zoetis Inc
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Onderstepoort Biological Products SOC Ltd
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Green Cross Veterinary Products Co Ltd
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Veterinary Serum & Vaccine Research Institute
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. CAVAC ChoongAng Vaccine Laboratories Co Ltd
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments